U.S. Markets close in 1 hr 41 mins

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
171.58+1.54 (+0.91%)
As of 2:19PM EDT. Market open.
People also watch
Full screen
Previous Close170.04
Bid171.71 x 100
Ask171.75 x 400
Day's Range170.14 - 172.63
52 Week Range133.64 - 184.21
Avg. Volume3,162,356
Market Cap125.2B
PE Ratio (TTM)16.30
Earnings DateN/A
Dividend & Yield4.60 (2.68%)
Ex-Dividend Date2017-08-15
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist4 hours ago

    What We May See from Amgen’s Vectibix in 2017

    In 2Q17, Amgen’s (AMGN) Vectibix generated revenues of ~$168 million, which represented a ~5% YoY (year-over-year) rise and a ~14% QoQ (quarter-over-quarter) rise. In the US, Vectibix generated revenues ...

  • Barrons.com4 hours ago

    Biogen: Goldman Has Conviction!

    Biogen (BIIB) has had a good, though not great year. Is it time to add it to your portfolio? Shares of Biogen have gained 11.5% so far this year, and while that's better than the S&P 500's 10.3% rise during ...

  • Market Realist5 hours ago

    How Amgen’s Neutropenia Drugs Are Positioned after 2Q17

    In 2Q17, Amgen’s (AMGN) Neulasta generated revenues of ~$1.1 billion, which represented a ~5% YoY (year-over-year) fall and ~10% QoQ (quarter-over-quarter) fall. In the US, Neulasta generated revenues ...